ICU sleep breakthrough? new drug trial aims for restful nights
NCT ID NCT06824077
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a medication called dexmedetomidine can help patients in the intensive care unit (ICU) sleep more restfully. Good sleep is important for recovery, but ICU conditions often disrupt it. About 50 adult ICU patients will either receive the medication or a placebo for two nights, and their sleep quality will be measured with a portable sleep monitor. The goal is to see if this approach improves sleep and helps patients feel more alert the next day.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DELIRIUM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A 45-Minute lesson could sharpen Students' minds and sleep
- Can a sleepless night rewire hunger and memory?
- Melatonin bath products: are they absorbed like pills?
- Can a strange bed sabotage your workout? sex differences put to the test
- Can a dissolvable film quiet ICU delirium?
- Can your pupils reveal the secrets of sleep and body clocks?